FDA Investigator Robin P Mathew

Robin P Mathew has conducted inspections on 25 sites in 4 countries as of 20 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
25
Last Inspection Date:
20 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100003522
Countries of Inspections:
Mexico, United States of America, India, China
FDA Investigators that have inspected at least one site in common with Robin P Mathew:
Adetutu M Gidado, Alberto A Viciedo, Amy L Singer, Amy M Cramer, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Annemarie Bodnar, Annet R Rajan, Anthony A Charity, Anthony J Donato, Antoinette L Ravelli, Asia D Clark, Barbara J Maulfair, Barbara Jwilimczyk Macri, Cary Greene, Charles I Ann, Charlotte P Chang, Constantin Y Philopoulos, Craig D Zagata, Cynthia Jim, CSO, Deborah J Parris, Dhaval H Patel, Dinesh Kumar, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Edwin Martinez, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Erin D Mccaffery, Esteban Beltran, Frank Wackes, Frederick F Razzaghi, Gabrielle J Swain, Gianine E Tompkins, Guerlain Ulysse, H Ljamilla Selby, Haitao Li, Hala L Selby, Helen B Ricalde, Helen Verdel, Heriberto Negron Rivera, James M Mason, Janet A Rajan, Javier E Santos, Jawaid Hamid, Jessica M Monteiro, Jill Mielziner, Jogy George, John D Mcintosh, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph L Despins, PhD, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Junho Pak, Justin A Boyd, Justine Tomasso, Karen A Spencer, Karen E D'orazio, Karishma G Gopaul, Karthik B Iyer, Karyn M Campbell, Kelli F Dobilas, Kendra L Brooks, Kham Phommachanh, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Kshitij A Patkar, Larry K Austin, Lata C Mathew, PhD, Lawrence R Johnson, LCDR Susan E Polifko, Liatte Kreuger, PharmD, Luis A Dasta, Maotang Zhou, PhD, Maria Estrella, Marijo B Kambere, PhD, Mary Davis Lopez, Mary E Storch, Matthew A Spataro, Matthew R Noonan, Melissa T Roy, Michael A Taylor, Michael L Casner, Michael R Klapal, Michael Serrano, Mindy M Chou, Monika Borkowska, Muralidhara B Gavini, PhD, Nancy F Scheraga, Nancy M Espinal, Naveen B Kanthamneni, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Niketa Patel, Nikhil Thakur, Paul L Bellamy, Pratibha Bhat, Puspa Suresh Jayasekara, Raymond L Cheung, Regina T Brown, Richard W Thornton, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Sam Pepe, Sarah Adella Fave, Satheesh Thomas, Sidney B Priesmeyer, Sony Mathews, Stelios C Tsinontides, Stephen D Brown, Stephen J Mottola, Stephenie M Ortiz, Steven D Kehoe, Susan F Laska, MS, Tamil Arasu, PhD, Tania E Vizcaino, Tanya R Syffrard, Tara G Bizjak, Temar Q Williams, Thomas E Friel, Tonia F Bernard, Unnee Ranjan, Victoria Spivak, Vlada Matusovsky, Yvins Dezan, Yvonne C Mcknight, Yvonne C Wood, Zakaria I Ganiyu, Zhijin Chen

Robin P Mathew's Documents

Publish Date Document Type Title
September, 2022 EIR Pfizer Inc - EIR, 2022-09-28
July, 2023 FDA 483 Aspire Pharmaceuticals Inc. - Form 483, 2023-07-14
May, 2023 FDA 483 Chartwell Pharmaceuticals Congers, LLC. - Form 483, 2023-05-24
May, 2021 FDA 483 Response HOVIONE LLC - Form 483R, 2022-02-18
November, 2021 FDA 483 Advanced Accelerator Applications USA, Inc. - Form 483, 2021-11-09
May, 2021 FDA 483 HOVIONE LLC - Form 483, 2021-05-28
July, 2021 FDA 483 Novitium Pharma LLC - Form 483, 2021-07-08
November, 2022 FDA 483 Advanced Accelerator Applications USA, Inc. - Form 483, 2022-11-03
November, 2022 EIR Advanced Accelerator Applications USA, Inc. - EIR, 2022-11-03
November, 2021 EIR Advanced Accelerator Applications USA, Inc. - EIR, 2021-12-08
February, 2023 FDA 483 Halo Pharmaceuticals Inc. - Form 483, 2023-02-17
August, 2023 EIR Advanced Accelerator Applications USA, Inc. - EIR, 2023-10-06
November, 2022 FDA 483 HOVIONE LLC - Form 483, 2022-11-17
November, 2021 FDA 483 Response Advanced Accelerator Applications USA, Inc. - Form 483R, 2021-12-02
December, 2021 FDA 483 EuTech Scientific Services, Inc. - Form 483, 2021-12-28
October, 2020 FDA 483 Unipack LLC - Form 483, 2020-10-16
November, 2022 FDA 483 Response Advanced Accelerator Applications USA, Inc. - Form 483R, 2022-11-03
March, 2024 EIR Everest Organics Limited - EIR, 2024-05-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more